Compounded (US 503A)· 503A
Compounded preparation (US 503A)
Patient-specific preparation from a US 503A pharmacy. Requires a valid prescription and is not an FDA-approved finished drug. Verify the pharmacy's licence and the active ingredient's status on the FDA 503A bulks list.
Empower Pharmacy
Empower Tirzepatide
10 mg/mL, 2 mL vial · US — 503A
Provenance
80n=20
Quality
74n=145
Two independent scores. Never blended into a single number.
Notes
FDA removed tirzepatide from shortage in 2024 — verify pharmacy is still compounding lawfully.
Active peptide